Impaired PGE2-stimulated Cl- and HCO3- secretion contributes to cystic fibrosis airway disease

PLoS One. 2017 Dec 27;12(12):e0189894. doi: 10.1371/journal.pone.0189894. eCollection 2017.

Abstract

Background: Airway mucociliary clearance (MCC) is an important defense mechanism against pulmonary infections and is compromised in cystic fibrosis (CF). Cl- and HCO3- epithelial transport are integral to MCC. During pulmonary infections prostaglandin E2 (PGE2) production is abundant.

Aim: To determine the effect of PGE2 on airway Cl- and HCO3- secretion and MCC in normal and CF airways.

Methods: We examined PGE2 stimulated MCC, Cl- and HCO3- secretion using ferret trachea, human bronchial epithelial cell cultures (CFBE41o- with wildtype CFTR (CFBE41 WT) or homozygous F508del CFTR (CFBE41 CF) and human normal bronchial submucosal gland cell line (Calu-3) in Ussing chambers with or without pH-stat.

Results: PGE2 stimulated MCC in a dose-dependent manner and was partially impaired by CFTRinh-172. PGE2-stimulated Cl- current in ferret trachea was partially inhibited by CFTRinh-172, with niflumic acid eliminating the residual current. CFBE41 WT cell monolayers produced a robust Cl- and HCO3- secretory response to PGE2, both of which were completely inhibited by CFTRinh-172. CFBE41 CF cells exhibited no response to PGE2. In Calu-3 cells, PGE2 stimulated Cl- and HCO3- secretion. Cl- secretion was partially inhibited by CFTRinh-172, with additional inhibition by niflumic acid. HCO3- secretion was completely inhibited by CFTRinh-172.

Conclusions: PGE2 stimulates bronchotracheal MCC and this response is decreased in CF. In CF airway, PGE2-stimulated Cl- and HCO3- conductance is impaired and may contribute to decreased MCC. There remains a CFTR-independent Cl- current in submucosal glands, which if exploited, could represent a means of improving airway Cl- secretion and MCC in CF.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bicarbonates / metabolism*
  • Bronchi / drug effects*
  • Bronchi / metabolism
  • Bronchi / pathology
  • Cells, Cultured
  • Chlorides / metabolism*
  • Cystic Fibrosis / metabolism*
  • Dinoprostone / pharmacology*
  • Humans
  • In Vitro Techniques
  • Trachea / drug effects*
  • Trachea / metabolism

Substances

  • Bicarbonates
  • Chlorides
  • Dinoprostone

Grants and funding

This research was supported by the Cystic Fibrosis Foundation (www.cff.org; SELLER15B0, SELLER16LO to Z.M.S.; ILLEK15P0, ILLEK16G0 to B.I.; WINE17G0, WINE07XXO to JJW), Elizabeth Nash Foundation (http://www.elizabethnashfoundation.org; BI), and CAPES (http://www.capes.gov.br; 10054-14-6 to MFF).